AptarGroup: Solid Strategic Position and Structural Growth Offset by Near-Term Earnings Headwinds, Warranting a Hold Rating

George Staphos, an analyst from Bank of America Securities, maintained the Hold rating on AptarGroup. The associated price target remains the same with $147.00.

George Staphos has given his Hold rating due to a combination of factors, emphasizing that AptarGroup’s strong strategic position is offset by nearer‑term earnings pressures. Management’s outlook at BofA’s Global Agriculture & Materials Conference was upbeat, with continued confidence in execution across the Pharma, Beauty, and Closures segments and first‑quarter 2026 EPS guidance reaffirmed as in line with prior expectations.

At the same time, Staphos highlights that while margins are expected to stay within the 21–23% range and China remains a particularly profitable market, the company faces a notable short‑term profit drag from a $65 million emergency‑medicine headwind in the first half of 2026. He also acknowledges structural growth drivers such as expanding GLP‑1‑related Injectables demand, but concludes that these positives are largely reflected in the current share price, justifying a Neutral stance rather than a more aggressive rating.